Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Argentina Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20113
20121
20132
20141
20153
20162
20174
20182
20194
20204
20214
20225
20234
20242
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated10
Active, not recruiting8
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Amgen3
Bristol-Myers Squibb3
Genentech, Inc.3
GlaxoSmithKline3
AbbVie2
Anthera Pharmaceuticals2
EMD Serono2
EMD Serono Research & Development Institute, Inc.2
Eli Lilly and Company2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic46
Autoimmune Diseases6
Lupus Nephritis5
Lupus Erythematosus, Cutaneous3
Arthritis, Rheumatoid2
Connective Tissue Diseases2
Immune System Diseases2
Lupus Erythematosus, Discoid2
Proteinuria1

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.